Key Takeaways
What Does ADHD Online Mean? Telehealth Diagnosis, Prescribing and Therapy
"ADHD online" usually means getting an ADHD evaluation, a medication prescription or therapy through video or phone visits instead of an office. It is now routine: in a 2023 national survey, 46.0% of U.S. adults with current ADHD said they had ever received telehealth services for the condition[1].
In the same NCHS Rapid Surveys System data, 30.5% of adults with ADHD had used a telehealth visit to get an ADHD prescription since March 2020, and 30.8% had used one for counseling or therapy[1]. Among adults who had used telehealth for ADHD, 8.9% were diagnosed through telehealth visits only and 9.5% through a mix of telehealth and in-person visits[1].
Online ADHD care sits under three sets of rules: clinical standards for diagnosis, federal Drug Enforcement Administration (DEA) rules for prescribing controlled stimulants, and state licensing law. For how many people have the condition, see the ADHD statistics page and the page on adults with ADHD; this article covers how the online route works and what studies show about it.
How U.S. Adults With ADHD Used Telehealth, 2023
| Telehealth use for ADHD | Share of adults with current ADHD |
|---|---|
| Ever received telehealth services for ADHD | 46.0% |
| Used telehealth to get an ADHD prescription (since March 2020) | 30.5% |
| Used telehealth for ADHD counseling or therapy (since March 2020) | 30.8% |
| Diagnosed through telehealth visits only* | 8.9% |
| Diagnosed through a mix of telehealth and in-person visits* | 9.5% |
| Diagnosed through in-person visits only* | 81.7% |
Self-reported telehealth use among 444 U.S. adults with current ADHD, NCHS Rapid Surveys System, October–November 2023[1].
1*Among U.S. adults with current ADHD who had ever used telehealth for ADHD (diagnosis rows only)[1].
2Respondents could report both prescription and therapy visits, so those rows overlap[1].
Sources
- •CDC, MMWR, 2024
Can You Get Diagnosed With ADHD Online?
A licensed clinician can diagnose ADHD over video because the diagnosis rests on a clinical interview and history, not a lab or imaging test. CDC states there is no single test to diagnose ADHD and that sleep disorders, anxiety, depression and some learning disabilities can produce similar symptoms[5]. The diagnosis can be made by a psychologist, a psychiatrist or a primary care provider such as a pediatrician[5].
For children, the American Academy of Pediatrics recommends asking parents, teachers and other caregivers about behavior at home, at school and with peers[5]. CDC also lists a medical exam with hearing and vision tests as one step in a child's evaluation, which a video visit alone cannot complete[5].
On accuracy, a 2025 meta-analysis of 22 studies found "almost perfect" agreement between telepsychiatry and face-to-face diagnoses across 16 psychiatric disorders (Cohen's kappa 0.824)[7]. Within one included study, agreement for individual disorders ranged from almost perfect to near zero, and the authors concluded that suitability varies by disorder, symptom and assessment method[7].
A 2024 expert consensus statement on telepsychiatry and ADHD encourages clinicians to use outside informants to confirm the history, to use rating scales, and to have access to a hybrid of in-person and remote care[8]. Step-by-step options for adults and children are covered in how to get tested for ADHD.
DEA telemedicine flexibilities
Temporary federal rules, first adopted during the COVID-19 public health emergency, that let a DEA-registered practitioner prescribe Schedule II–V controlled substances by telemedicine without first examining the patient in person, if set conditions are met[3]. The fourth extension, published in December 2025, runs through December 31, 2026[3].
Related Terms
Source: Federal Register (DEA and HHS), 2025
Are Online ADHD Tests Accurate?
Free online ADHD quizzes are screeners, not diagnoses. The best-studied adult screener, the six-question World Health Organization Adult ADHD Self-Report Scale for DSM-5 (ASRS-5), identified 91.4% of adults who met DSM-5 criteria in a general-population sample, with 96.0% specificity, in its 2017 validation study[6].
Performance dropped in a clinic sample of people seeking an ADHD evaluation, where specificity was 74.0%, meaning about 1 in 4 people without ADHD still screened positive[6]. That is the setting most online test-takers resemble: people who already suspect ADHD.
A screener also cannot rule out the look-alike conditions CDC lists, such as anxiety, depression and sleep disorders[5]. A full comparison of screening tools and what each measures is in ADHD test.
Can You Get ADHD Medication Online? The DEA Rules for 2026
Stimulants such as Adderall are Schedule II controlled substances[11]. The Ryan Haight Act normally limits online prescribing of these drugs without a face-to-face evaluation, and its suspension during the pandemic allowed stimulants to be prescribed without one[8].
Under the current temporary rule, a DEA-registered practitioner may prescribe Schedule II–V controlled substances by telemedicine without an in-person medical evaluation from May 12, 2023, through December 31, 2026[3]. The prescription must be for a legitimate medical purpose in the usual course of practice, must follow a live interactive telecommunications visit, and must meet all other federal prescription rules[3].
HHS describes the rule as extending the full set of COVID-era telemedicine flexibilities through December 31, 2026[2]. The rule does not say what will replace them; DEA wrote that the extension gives it time to consider listening sessions, tribal consultations and other input[3].
Online starts are a large share of stimulant prescribing. In national commercial insurance claims, telemedicine accounted for 53% to 57% of new stimulant starts at its April 2020 peak, falling to about 14% for children and 28% for adults by April 2022[4].
A stakeholder summary of unpublished Epic, Johns Hopkins and Stanford data, cited in the 2025 rule, estimated that more than 7 million of 44.6 million controlled-substance prescriptions in 2024, about 16%, were issued without a prior in-person evaluation[3]. That figure covers all controlled substances, not only ADHD drugs.
The 2024 consensus statement calls for closer scrutiny of young adults with no prior ADHD diagnosis or treatment who request immediate-release stimulants, and says nonstimulants, controlled-release stimulants or psychosocial treatment should be prioritized in those cases[8]. Drug classes are compared in ADHD meds, and prescriber types in ADHD psychiatrist.
U.S. adults with current ADHD who had ever used telehealth for ADHD care, 2023
Roughly 1 in 2 adults with ADHD had used telehealth for the condition, yet 81.7% of those users said their diagnosis came from in-person visits only.
"Almost one half of adults with ADHD (46.0%) reported ever receiving telehealth services for their condition"
Is Getting ADHD Medication Online Riskier? What Studies Show
The main safety question is whether starting stimulants by telehealth leads to more misuse or substance use disorders. Two 2025 studies reached partly different answers[9][10].
A Health Affairs study of 77,153 patients ages 12 to 64 who started stimulants in 2021 found new substance use disorder diagnoses within a year in 3.7% of telehealth starts and 3.2% of in-person starts[10]. The telehealth group also had more psychiatric conditions, and after adjusting for them, telehealth initiation was not an independent risk factor, except among people ages 26 to 34[10].
An American Journal of Psychiatry study of 7,944 patients age 12 and older in one Northeastern health system (2020 to 2023) found that a purely telehealth relationship with the prescriber did not significantly change the risk of any substance use disorder[9]. Receiving the first stimulant prescription at a telehealth appointment, however, was associated with higher odds of a later stimulant use disorder (adjusted odds ratio 6.18, 95% CI 1.34 to 28.46)[9]. The interval is wide and the design is observational, so the finding is an association, not proof of cause[9].
Follow-up care ran the other way. Adults whose stimulant treatment began by telemedicine were more likely to have a follow-up visit than those who started in person (odds ratio 1.61), and children showed a smaller difference (odds ratio 1.09)[4].
Studies Comparing Telehealth and In-Person Stimulant Starts
| Study | Population | Main finding |
|---|---|---|
| Huskamp et al., Psychiatric Services, 2024 | Commercial claims, 2019–2022; 535,629 children, 2,116,160 adults | Telemedicine starts more likely to get follow-up (adults OR 1.61) |
| Constantin et al., Health Affairs, 2025 | 77,153 patients ages 12–64 starting stimulants in 2021 | New SUD 3.7% vs 3.2%; not significant after adjusting for psychiatric conditions |
| Rao et al., Am J Psychiatry, 2025 | 7,944 patients 12+, one health system, 2020–2023 | No change in overall SUD risk; telehealth first prescription linked to stimulant use disorder (aOR 6.18) |
1SUD = substance use disorder; OR = odds ratio; aOR = adjusted odds ratio. All three studies are observational and show associations[4][9][10].
Sources
- •Psychiatric Services, 2024
- •Health Affairs, 2025
- •American Journal of Psychiatry, 2025
What the Done Global Case Showed About Online ADHD Platforms
Done Global, a subscription telehealth platform for adult ADHD, became the subject of a federal criminal case. In July 2026, DOJ announced that its founder and CEO was sentenced to 72 months in prison and its clinical president to 24 months for a scheme that, according to DOJ, distributed more than 37 million Adderall pills and defrauded insurers of more than $12 million[11].
DOJ said trial evidence showed clinicians were pressured to diagnose ADHD in first visits capped at half the length of a typical exam, and that an auto-refill feature let some patients go years without seeing a clinician[11]. A jury convicted both executives in November 2025[11].
When the indictment was announced in June 2024, CDC issued a health advisory estimating that a disruption at the company could affect 30,000 to 50,000 patients ages 18 and older in all 50 states[12]. CDC warned that patients who lose access and turn to pills from outside licensed pharmacies face overdose risk from counterfeit pills, and told pharmacists the indictment should not lead to blanket refusals of telehealth prescriptions[12].
The advisory came during a shortage of several ADHD stimulants[12]. In the 2023 NCHS survey, 71.5% of adults taking a stimulant reported trouble filling a prescription in the past year because the drug was unavailable[1]. National prescription trends are tracked in ADHD medication statistics.
Does Online Therapy for ADHD Work?
Online ADHD care also covers therapy: 30.8% of adults with ADHD reported using telehealth for ADHD counseling or therapy since March 2020[1]. The survey counted video or phone visits with a health professional; self-paced internet programs are a separate format tested in trials[1].
In a 2023 randomized trial of 104 adult outpatients with ADHD, 67% of whom took ADHD medication, 12 weeks of internet-delivered cognitive behavioral therapy (iCBT) or internet-delivered applied relaxation reduced self-rated ASRS symptoms more than treatment as usual, with effects lasting 12 months[13]. Treatment response reached 25% in both internet groups versus 3% with usual care, and iCBT did not outperform the relaxation program[13].
The authors framed both programs as add-ons to medication rather than replacements[13]. How in-person and group CBT compare is covered in CBT for ADHD.
Frequently Asked Questions
Sources & References
- Staley BS, Robinson LR, Claussen AH, et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. MMWR Morb Mortal Wkly Rep. Centers for Disease Control and Prevention. Published 2024. Accessed October 2026. https://www.cdc.gov/mmwr/volumes/73/wr/mm7340a1.htm [Link]
- U.S. Department of Health and Human Services. Prescribing Controlled Substances via Telehealth. Telehealth.HHS.gov. Published 2026. Accessed October 2026. https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth [Link]
- Drug Enforcement Administration, U.S. Department of Health and Human Services. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Federal Register. Published 2025. Accessed October 2026. https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled [Link]
- Huskamp HA, Uscher-Pines L, Raja P, Normand SLT, Mehrotra A, Busch AB. Trends in Use of Telemedicine for Stimulant Initiation Among Children and Adults. Psychiatric Services. American Psychiatric Association. Published 2024. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ps.20230421 [Link]
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. Diagnosing ADHD. CDC. Published 2026. Accessed October 2026. https://www.cdc.gov/adhd/diagnosis/index.html [Link]
- Ustun B, Adler LA, Rudin C, et al. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. JAMA Psychiatry. American Medical Association. Published 2017. Accessed October 2026. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2616166 [Link]
- Fujikawa M, Hagi K, Kinoshita S, et al. Diagnosis and Symptom Assessment in Telepsychiatry vs. Face-to-Face Settings: A Systematic Review and Meta-Analysis. Psychiatry and Clinical Neurosciences. Wiley. Published 2025. Accessed October 2026. https://onlinelibrary.wiley.com/doi/10.1111/pcn.13860 [Link]
- Hong J, Mattingly GW, Carbray JA, et al. Expert Consensus Statement for Telepsychiatry and Attention-Deficit Hyperactivity Disorder. CNS Spectrums. Cambridge University Press. Published 2024. Accessed October 2026. https://doi.org/10.1017/S1092852924000208 [Link]
- Rao V, Lanni S, Yule AM, et al. Telehealth Prescribing of Stimulants for ADHD and Associated Risk for Later Stimulant and Substance Use Disorders. American Journal of Psychiatry. American Psychiatric Association. Published 2025. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ajp.20240346 [Link]
- Constantin J, McCabe SE, Pasman E, Wilens T, Chua KP. Association Between Telehealth Initiation of Stimulant Therapy and New Substance Use Disorder Diagnoses. Health Affairs. Published 2025. Accessed October 2026. https://www.healthaffairs.org/doi/10.1377/hlthaff.2024.01026 [Link]
- Office of Public Affairs, U.S. Department of Justice. Founder/CEO and Clinical President of Digital Health Company Sentenced to 72 Months and 24 Months, Respectively, for $90 Million Scheme to Distribute over 37 Million Pills of Adderall. Published 2026. Accessed October 2026. https://www.justice.gov/opa/pr/founderceo-and-clinical-president-digital-health-company-sentenced-8-years-90-million-scheme [Link]
- CDC Health Alert Network. Disrupted Access to Prescription Stimulant Medications Could Increase Risk of Injury and Overdose (HAN-00510). Centers for Disease Control and Prevention. Published 2024. Accessed October 2026. https://www.cdc.gov/han/2024/han00510.html [Link]
- Nasri B, Cassel M, Enhärje J, et al. Internet Delivered Cognitive Behavioral Therapy for Adults With ADHD: A Randomized Controlled Trial. Internet Interventions. Elsevier. Published 2023. Accessed October 2026. https://doi.org/10.1016/j.invent.2023.100636 [Link]